SIRIC ILIAD 2023-2027

Labeled for the second consecutive time in 2023 by the INCa, the ILIAD project is one of the eight SIRICs based on the Comprehensive Care Centers’ research integration model.

Organized around a research-care continuum, ILIAD brings together medical, scientific, and technological expertise while combining different disciplines.

ILIAD relies on integrated, innovative, and multidisciplinary research to detect, treat, and ensure sustainable employment for high-risk patients. Centered around the care pathway, the research conducted by ILIAD teams also focuses on patients’ life paths, incorporating issues of social inequalities and employment retention in the face of illness.

The research programs are implemented on two selected tumors as demonstrators: multiple myeloma and breast cancer.

Predict and characterize high-risk patients.
Develop early detection of high-risk patients to tailor treatments and offer personalized therapies.

Tumor resistance and innovative therapies. Understand the resistance of tumor ecosystems to develop and evaluate innovative therapies.

Develop tools to identify and address inequalities in cancer care and promote sustainable employment retention after cancer.

NEWS

A new cyclotron co-operated by GIP ARRONAX and Curium PET France

23 September 2024

The GIP Arronax and Curium PET France have partnered to co-operate the new 18 MeV Cyclotron. This technology will enable the production of radiopharmaceutical drugs such as Fluorine-18: “When we decided

New Certification for CLIP²-ILIAD!

16 September 2024

The CLIP²-ILIAD (Imaging and Longitudinal Investigations to Ameliorate Decision-making) has been awarded the prestigious certification for the fourth time! This project, led by the GCS IRéCAN (Institut de Cancérologie de

Public lecture: Breast cancer & work – October 10, 2024

9 September 2024

As part of Breast Cancer Awareness Month, SIRIC ILIAD and the Cancéropôle Grand Ouest are organizing the 4th edition of the public conference “Perspectives on Breast Cancer” on October 10,

2nd edition of the hematology patient associations day – September 17, 2024

14 August 2024

On the occasion of Blood Cancer Awareness Month, SIRIC ILIAD is pleased to participate in the 2nd edition of the hematology patient associations day. Blood cancers, or hematologic malignancies, include

📣 [PhD recruitment] Deep learning radiomics for early-stage poor prognosis breast cancer

7 August 2024

The SIRIC ILIAD teams involved in WP3 of the PRECIZE program are recruiting a PhD student for the 2024 academic year to work at the Laboratory of Digital Sciences of

Astatine-211 for radiotherapy

22 July 2024

Congratulations to the CRCI2NA researchers for their article on the use of astatine-211 for radiotherapy, which has graced the cover of eBioMedicine, published by The Lancet, in July 2024. The